Main public logs
Combined display of all available logs of CAMIH. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).
- 08:34, 19 September 2024 CHoppe talk contribs created page Keshavarzi et al. (2019): The effect of vitamin D and E vaginal suppositories on tamoxifen-induced vaginal atrophy in women with breast cancer (Created page with "{{Reference |Reference=Publication: The effect of vitamin D and E vaginal suppositories on tamoxifen-induced vaginal atrophy in women with breast cancer }} {{Study Note}} =Brief summary= In this study, the influence of vitamin D and E on vaginal atrophy in breast cancer patients undergoing hormone therapy was investigated. Vaginal atrophy includes symptoms such as itching, burning and pain during sexual intercourse, which are caused by a lack of oestrogen. The 96 partici...")
- 08:32, 19 September 2024 CHoppe talk contribs created page Publication: The effect of vitamin D and E vaginal suppositories on tamoxifen-induced vaginal atrophy in women with breast cancer (Created page with "{{Publication |Title=The effect of vitamin D and E vaginal suppositories on tamoxifen-induced vaginal atrophy in women with breast cancer |Topic=Vitamin D |Author=Keshavarzi, Z; Janghorban, R; Alipour, S; Tahmasebi, S; Jokar, A |Year=2019 |Journal=Supportive Care in Cancer |DOI=https://doi.org/10.1007/s00520-019-04684-6 |Authors Abstract=Purpose: Vaginal atrophy is one of the most common side effects of using tamoxifen in women with breast cancer. Hormone therapy for vag...")
- 07:54, 19 September 2024 CHoppe talk contribs created page Antunac et al. (2018): Vitamin D Supplementation and Survival in Metastatic Colorectal Cancer (Created page with "{{Reference |Reference=Publication: Vitamin D Supplementation and Survival in Metastatic Colorectal Cancer }} {{Study Note}} =Brief summary= This study compared the efficacy of treatment of metastatic colorectal cancer (mCRC) with standard chemotherapy alone and standard chemotherapy in combination with cholecalciferol 2000 IU daily. All but one patient had a vitamin D deficiency. The results at 46 months showed that 2,000 IU of vitamin D daily had no effect on disease-f...")
- 07:53, 19 September 2024 CHoppe talk contribs created page Publication: Vitamin D Supplementation and Survival in Metastatic Colorectal Cancer (Created page with "{{Publication |Title=Vitamin D Supplementation and Survival in Metastatic Colorectal Cancer |Topic=Vitamin D |Author=Antunac Golubić, Z; Baršić, I; Librenjak, N; Pleština, S |Year=2018 |Journal=Nutrition and cancer |DOI=https://doi.org/10.1080/01635581.2018.1445766 |Authors Abstract=Background: Some studies have demonstrated that higher baseline plasma levels of 25-hydroxivitamin D [25(OH)D] are associated with a significant reduction in colorectal cancer (CRC) incid...")
- 13:56, 17 September 2024 CHoppe talk contribs created page Inglis et al. (2020): Effects of High-Dose Vitamin D Supplementation on Phase Angle and Physical Function in Patients with Prostate Cancer on ADT (Created page with "{{Reference |Reference=Publication: Effects of High-Dose Vitamin D Supplementation on Phase Angle and Physical Function in Patients with Prostate Cancer on ADT }} {{Study Note}} =Brief summary= The 59 patients suffering from prostate cancer and treated with androgen deprivation therapy were randomly divided into two arms. 29 patients received daily high-dose vitamin D and 30 patients received a placebo, and both arms received a multivitamin (low dose of vitamin D and cal...")
- 13:54, 17 September 2024 CHoppe talk contribs created page Publication: Effects of High-Dose Vitamin D Supplementation on Phase Angle and Physical Function in Patients with Prostate Cancer on ADT (Created page with "{{Publication |Title=Effects of High-Dose Vitamin D Supplementation on Phase Angle and Physical Function in Patients with Prostate Cancer on ADT |Topic=Vitamin D |Author=Inglis, JE; Fernandez, ID; Wijngaarden, Ev; Culakova, E; Reschke, JE; Kleckner, AS; Lin, P-J; Mustian, KS; Peppone, LJ |Year=2020 |Journal=Nutrition and cancer |DOI=https://doi.org/10.1080/01635581.2020.1819348 |Authors Abstract=Purpose: Androgen deprivation therapy (ADT) is commonly used to treat patien...")
- 09:28, 17 September 2024 CHoppe talk contribs created page Urashima et al. (2019): Effect of Vitamin D Supplementation on Relapse-Free Survival Among Patients With Digestive Tract Cancers The AMATERASU Randomized Clinical Trial (Created page with "{{Reference |Reference=Publication: Effect of Vitamin D Supplementation on Relapse-Free Survival Among Patients With Digestive Tract Cancers The AMATERASU Randomized Clinical Trial }} {{Study Note}} =Brief summary= The study included 417 patients with carcinomas of the digestive tract. They were randomly divided into 2 arms. One arm received 2000 IU of vitamin D daily and the other arm a placebo. No differences were found between the arms for relapse-free survival at 5 y...")
- 09:26, 17 September 2024 CHoppe talk contribs created page Publication: Effect of Vitamin D Supplementation on Relapse-Free Survival Among Patients With Digestive Tract Cancers The AMATERASU Randomized Clinical Trial (Created page with "{{Publication |Title=Effect of Vitamin D Supplementation on Relapse-Free Survival Among Patients With Digestive Tract Cancers The AMATERASU Randomized Clinical Trial |Topic=Vitamin D |Author=Urashima, M; Ohdaira, H; Akutsu, T; Okada, S; Yoshida, M; Kitajima, M; Suzuki, Y |Year=2019 |Journal=JAMA |DOI=https://doi.org/10.1001/jama.2019.2210 |Authors Abstract=Importance: Randomized clinical trials of vitamin D supplementation for secondary prevention in patients with cancer...")
- 13:54, 12 September 2024 CHoppe talk contribs created page Niravath et al. (2019): Randomized controlled trial of high‐dose versus standard‐dose vitamin D3 for prevention of aromatase inhibitor‐induced arthralgia (Created page with "{{Reference |Reference=Publication: Randomized controlled trial of high‐dose versus standard‐dose vitamin D3 for prevention of aromatase inhibitor‐induced arthralgia }} {{Study Note |Study Note=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-9...")
- 13:52, 12 September 2024 CHoppe talk contribs created page Publication: Randomized controlled trial of high‐dose versus standard‐dose vitamin D3 for prevention of aromatase inhibitor‐induced arthralgia (Created page with "{{Publication |Title=Randomized controlled trial of high‐dose versus standard‐dose vitamin D3 for prevention of aromatase inhibitor‐induced arthralgia |Topic=Vitamin D |Author=Niravath, P; Hilsenbeck, SG; Wang, T; Jiralerspong, S; Nangia, J; Pavlick, A; Ademuyiwa, F; Frith, A; Ma, C; Park, H; Rigden, C; Suresh, R; Ellis, M; Osborne, CK; Rimawi, MF |Year=2019 |Journal=Breast cancer research and treatment |DOI=https://doi.org/10.1007/s10549-019-05319-4 |Authors Ab...")
- 11:41, 12 September 2024 CHoppe talk contribs created page Raoufinejad et al. (2019): Oral calcitriol in hematopoietic recovery and survival after autologous stem cell transplantation: a randomized clinical trial (Created page with "{{Reference |Reference=Publication: Raoufinejad et al. (2019): Oral calcitriol in hematopoietic recovery and survival after autologous stem cell transplantation: a randomized clinical trial }} {{Study Note}} =Brief summary= The study included 80 patients with Hodgkin lymphoma, non-Hodgkin lymphoma and multiple myeloma awaiting stem cell transplantation with autologous peripheral blood. Randomly assigned, one half received 0.25 μg calcitriol 3 times a day for 30 days aft...")
- 11:38, 12 September 2024 CHoppe talk contribs created page Publication: Oral calcitriol in hematopoietic recovery and survival after autologous stem cell transplantation: a randomized clinical trial (Created page with "{{Publication |Title=Oral calcitriol in hematopoietic recovery and survival after autologous stem cell transplantation: a randomized clinical trial |Topic=Vitamin D |Author=Raoufinejad, K; Shamshiri, AR; Pezeshki, S; Chahardouli, B; Hadjibabaie, M; Jahangard-Rafsanjani, Z; Gholami, K; Rajabi, M; Vaezi, M |Year=2019 |Journal=Journal of Pharmaceutical Sciences |DOI=https://doi.org/10.1007/s40199-019-00306-y |Authors Abstract=Background Calcitriol, the active metabolite of...")
- 15:05, 11 September 2024 CHoppe talk contribs created page Akiba et al. (2018): Vitamin D Supplementation and Survival of Patients with Non–small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial (Created page with "{{Reference |Reference=Publication: Vitamin D Supplementation and Survival of Patients with Non–small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial }} {{Study Note}} =Brief summary= This study compared the efficacy of treatment of metastatic colorectal cancer (mCRC) with standard chemotherapy alone and standard chemotherapy in combination with cholecalciferol 2000 IU daily. All but one patient had a vitamin D deficiency. The results at 46 month...")
- 15:04, 11 September 2024 CHoppe talk contribs created page Publication: Vitamin D Supplementation and Survival of Patients with Non–small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial (Created page with "{{Publication |Title=Vitamin D Supplementation and Survival of Patients with Non–small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial |Topic=Vitamin D |Author=Akiba, T; Morikawa, T; Odaka, M; Nakada, T; Kamiya, N; Yamashita, M; Yabe, M; Inagaki, T; Asano, H; Mori, S; Tsukamoto, Y; Urashima, M |Year=2018 |Journal=Clinical Cancer Research |DOI=https://doi.org/10.1158/1078-0432.CCR-18-0483 |Authors Abstract=Purpose: Higher serum 25-hydroxyvitamin D...")
- 08:13, 11 September 2024 CHoppe talk contribs created page Frankling et al. (2021): ‘Palliative-D’ - Vitamin D Supplementation to Palliative Cancer Patients: A Double Blind, Randomized Placebo-Controlled Multicenter Trial (Created page with "{{Reference |Reference=Publication: ‘Palliative-D’ - Vitamin D Supplementation to Palliative Cancer Patients: A Double Blind, Randomized Placebo-Controlled Multicenter Trial }} {{Study Note}} =Brief summary= In the study, 244 patients were randomly divided into two groups. The patients suffered from advanced cancer and were receiving palliative care. One group received 4000 IU vitamin D3 daily for 12 weeks and the other group a placebo. The change in opioid dose, fat...")
- 08:11, 11 September 2024 CHoppe talk contribs deleted page Franklin et al: (2021): ‘Palliative-D’ - Vitamin D Supplementation to Palliative Cancer Patients: A Double Blind, Randomized Placebo-Controlled Multicenter Trial (content was: "{{Reference |Reference=Publication: ‘Palliative-D’ - Vitamin D Supplementation to Palliative Cancer Patients: A Double Blind, Randomized Placebo-Controlled Multicenter Trial }} {{Study Note}} =Brief summary= In the study, 244 patients were randomly divided into two groups. The patients suffered from advanced cancer and were receiving palliative care. One group received 4000 I...", and the only contributor was "CHoppe" (talk))
- 08:11, 11 September 2024 CHoppe talk contribs created page Franklin et al: (2021): ‘Palliative-D’ - Vitamin D Supplementation to Palliative Cancer Patients: A Double Blind, Randomized Placebo-Controlled Multicenter Trial (Created page with "{{Reference |Reference=Publication: ‘Palliative-D’ - Vitamin D Supplementation to Palliative Cancer Patients: A Double Blind, Randomized Placebo-Controlled Multicenter Trial }} {{Study Note}} =Brief summary= In the study, 244 patients were randomly divided into two groups. The patients suffered from advanced cancer and were receiving palliative care. One group received 4000 IU vitamin D3 daily for 12 weeks and the other group a placebo. The change in opioid dose, fat...")
- 08:09, 11 September 2024 CHoppe talk contribs deleted page Publication: ‘Palliative-D’ - Vitamin D Supplementation to Palliative Cancer Patients: A Double Blind, Randomized Placebo-Controlled Multicenter Trial. (content was: "{{Publication |Title=‘Palliative-D’ - Vitamin D Supplementation to Palliative Cancer Patients: A Double Blind, Randomized Placebo-Controlled Multicenter Trial. |Topic=Vitamin D |Author=Frankling, MH; Klasson, C; Sandberg, C; Nordström, M; Warnqvist, A; Bergqvist, J; Bergman, P; Björkhem-Bergman, L |Year=2021 |Journal=Cancers |DOI=https://doi.org/10.3390/ cancers13153707 |Au...", and the only contributor was "CHoppe" (talk))
- 08:09, 11 September 2024 CHoppe talk contribs created page Publication: ‘Palliative-D’ - Vitamin D Supplementation to Palliative Cancer Patients: A Double Blind, Randomized Placebo-Controlled Multicenter Trial (Created page with "{{Publication |Title=‘Palliative-D’ - Vitamin D Supplementation to Palliative Cancer Patients: A Double Blind, Randomized Placebo-Controlled Multicenter Trial |Topic=Vitamin D |Author=Frankling, MH; Klasson, C; Sandberg, C; Nordström, M; Warnqvist, A; Bergqvist, J; Bergman, P; Björkhem-Bergman, L |Year=2021 |Journal=Cancers |DOI=https://doi.org/10.3390/ cancers13153707 |Authors Abstract=The aim of the ‘Palliative-D’ study was to test the hypothesis that correct...")
- 08:07, 11 September 2024 CHoppe talk contribs created page Publication: ‘Palliative-D’ - Vitamin D Supplementation to Palliative Cancer Patients: A Double Blind, Randomized Placebo-Controlled Multicenter Trial. (Created page with "{{Publication |Title=‘Palliative-D’ - Vitamin D Supplementation to Palliative Cancer Patients: A Double Blind, Randomized Placebo-Controlled Multicenter Trial. |Topic=Vitamin D |Author=Frankling, MH; Klasson, C; Sandberg, C; Nordström, M; Warnqvist, A; Bergqvist, J; Bergman, P; Björkhem-Bergman, L |Year=2021 |Journal=Cancers |DOI=https://doi.org/10.3390/ cancers13153707 |Authors Abstract=The aim of the ‘Palliative-D’ study was to test the hypothesis that correc...")
- 06:16, 11 September 2024 CHoppe talk contribs created page Brown et al. (2019): Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Body Composition among Patients with Advanced or Metastatic Colorectal Cancer: A Randomized Trial (Created page with "{{Reference |Reference=Publication: Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Body Composition among Patients with Advanced or Metastatic Colorectal Cancer: A Randomized Trial }} {{Study Note}} =Brief summary= This study is a further analysis of the study by Ng et al (2019). A total of 105 patients with advanced or metastatic adenoma carcinomas were included, with the intervention group receiving high-dose vitamin D3 daily during chemotherapy (1s...")
- 06:15, 11 September 2024 CHoppe talk contribs created page Publication: Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Body Composition among Patients with Advanced or Metastatic Colorectal Cancer: A Randomized Trial (Created page with "{{Publication |Title=Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Body Composition among Patients with Advanced or Metastatic Colorectal Cancer: A Randomized Trial |Topic=Vitamin D |Author=Brown, JC; Rosenthal, MH; Ma, C; Zhang, S; Nimeiri, HS; McCleary NJ; Abrams, TA; Yurgelun, MB; Cleary, JM; Rubinson, DA; Schrag, D; Bullock, AJ; Allen, J; Zuckerman, D; Chan, E; Chan, JA; Wolpin, B; Constantine, M; Weckstein, DJ; Faggen, MA; Thomas, CA; Kournioti,...")
- 12:55, 10 September 2024 CHoppe talk contribs created page Hajimohammadebrahim-Ketabforoush et al. (2019): Effect of Vitamin D Supplementation on Postcraniotomy Pain After Brain Tumor Surgery: A Randomized Clinical Trial (Created page with "{{Reference |Reference=Publication: Effect of Vitamin D Supplementation on Postcraniotomy Pain After Brain Tumor Surgery: A Randomized Clinical Trial }} {{Study Note |Study Note=This study examined the effect of high-dose vitamin D3 before tumor surgery on the subjective perception of pain and the use of painkillers after surgery in 60 patients with brain tumors and low vitamin D levels. Three days after the operation, there were no significant differences between patien...")
- 12:53, 10 September 2024 CHoppe talk contribs created page Publication: Effect of Vitamin D Supplementation on Postcraniotomy Pain After Brain Tumor Surgery: A Randomized Clinical Trial (Created page with "{{Publication |Title=Effect of Vitamin D Supplementation on Postcraniotomy Pain After Brain Tumor Surgery: A Randomized Clinical Trial |Topic=Vitamin D |Author=Hajimohammadebrahim-Ketabforoush, M; Shahmohammadi, M; Khoundabi, B; Shariatpanahi, ZV |Year=2019 |Journal=World Neurosurgery |DOI=https://doi.org/10.1016/j.wneu.2019.05.250 |Authors Abstract=OBJECTIVE: To determine the effect of vitamin D supplementation on postoperative pain and analgesic requirement in brain tu...")
- 10:46, 10 September 2024 CHoppe talk contribs created page Johansson et al. (2021): Vitamin D Supplementation and Disease-Free Survival in Stage II Melanoma: A Randomized Placebo Controlled Trial (Created page with "{{Reference |Reference=Publication: Vitamin D Supplementation and Disease-Free Survival in Stage II Melanoma: A Randomized Placebo Controlled Trial }} {{Study Note |Study Note=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specific...")
- 10:45, 10 September 2024 CHoppe talk contribs created page Publication: Vitamin D Supplementation and Disease-Free Survival in Stage II Melanoma: A Randomized Placebo Controlled Trial (Created page with "{{Publication |Title=Vitamin D Supplementation and Disease-Free Survival in Stage II Melanoma: A Randomized Placebo Controlled Trial |Topic=Vitamin D |Author=Johansson, H; Spadola, G; Tosti, G; Mandalà, M; Minisini, AM; Queirolo, P; Aristarco, V; Baldini, F; Cocorocchio, E; Albertazzi, E; Zichichi, L; Cinieri, S; Jemos, C; Mazzarol,G; Gnagnarella, P; Macis, D; Tedeschi, I; Salè, EO; Stucci, LS; Bonanni, B; Testori, A; Pennacchioli E; Ferrucci, PF; Gandini, S; and on be...")
- 09:55, 13 August 2024 CHoppe talk contribs created page Ng et al. (2019): Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial (Created page with "{{Reference |Reference=Publication: Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial }} {{Study Note |Study Note=? }} =Brief summary= The study included 139 patients. Randomly divided into two groups, half received chemotherapy and additional high-dose vitamin D3 and the other half received additional standard-dose vitamin D3. T...")
- 09:51, 13 August 2024 CHoppe talk contribs created page Publication: Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial (Created page with "{{Publication |Title=Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial |Topic=Vitamin D |Author=Ng, K; Nimeiri, HS; McCleary, NJ; Abrams TA; Yurgelun, MB; Cleary, JM; Rubinson, DA; Schrag, D; Miksad, R; Bullock, AJ; Allen, J; Zuckerman, D; Chan, E; Chan, JA; Wolpin, BM; Constantine, M; Weckstein, DJ; Faggen, MA; Thomas, CA; Kourn...")
- 10:17, 5 July 2024 CHoppe talk contribs created page Walsh et al. (2010): Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma (Created page with "{{Reference |Reference=Publication: Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma }} {{Study Note |Study Note=In this study, two groups of neck and head tumor patients were compared with regard to the progression-free interval. One group received vitamin D for 3 weeks before the tumor operation and the other group received nothing. In the vitamin D group, it took significantly longer for the dise...")
- 10:16, 5 July 2024 CHoppe talk contribs created page Publication: Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma (Created page with "{{Publication |Title=Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma |Topic=Vitamin D |Author=Walsh, JE; Clark A-M; Day, TA; Gillespie, MB; Young, MRI |Year=2010 |Journal=Human immunology |DOI=10.1016/j.humimm.2010.04.008 |Authors Abstract=Prior studies have shown that treatment of head and neck squamous cell carcinoma (HNSCC) patients with 1alpha,25-dihydroxyvitamin D(3) [1,25(OH)(2)D(3)] reduced...")
- 14:00, 4 July 2024 CHoppe talk contribs created page Shapiro et al. (2016): Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS) (Created page with "{{Reference |Reference=Publication: Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS) }} {{Study Note}} =Brief summary= This study investigated the efficacy of high-dose vitamin D3 with regard to muscular symptoms associated with aromatase inhibitors. No significant differences were found between the arms that received high-dose vitamin D and the control arm that only received standard vitamin D therapy....")
- 13:56, 4 July 2024 CHoppe talk contribs created page Publication: Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS) (Created page with "{{Publication |Title=Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS) |Topic=Vitamin D |Author=Shapiro, AC; Adlis, SA; Robien, K; Kirstein, MN; Liang, S; Richter, SA; Lerner, RE |Year=2016 |Journal=Breast cancer Research and Treatment |DOI=10.1007/s10549-016-3710-6 |Authors Abstract=Purpose: To evaluate the efficacy and safety of vitamin D3 at 4,000 IU/day as a treatment option for aromatase inhibitor as...")
- 11:54, 4 July 2024 CHoppe talk contribs created page Scher et al. (2011): Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer (Created page with "{{Reference |Reference=Publication: Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer }} {{Study Note}} =Brief summary= In this study, prostate cancer patients were examined, with one half receiving docetaxel and a vitamin D analog (arm A) and the other half docetaxel and prednisone (arm B). Patients in arm A lived significantly shorter than those in arm B....")
- 11:52, 4 July 2024 CHoppe talk contribs created page Publication: Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer (Created page with "{{Publication |Title=Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer |Topic=Vitamin D |Author=Scher, H; Jia, X; Chi, K; Wit, R de; Berry, WR; Albers, P; Henick, B; Waterhouse, D; Ruether, DJ; Rosen, PJ; Meluch, AA; Nordquist, LT; Venner, PM; Heidenreich, A; Chu, L; Heller, G |Year=2011 |Journal=Journal of Clinical Oncology |DOI=10.1200/JCO.2010.32.8815 |A...")
- 10:34, 4 July 2024 CHoppe talk contribs created page Rastelli et al. (2011): Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial (Created page with "{{Reference |Reference=Publication: Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial }} {{Study Note}} =Brief summary= In this study, breast cancer patients who had already received aromatase inhibitor therapy for at least 8 weeks before the start of the study were examined with regard to typical side effects (musculoskeletal disorders, AIMSS) of this treatment. One arm received vit...")
- 10:30, 4 July 2024 CHoppe talk contribs created page Publication: Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial (Created page with "{{Publication |Title=Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial |Topic=Vitamin D |Author=Rastelli, AL; Taylor, ME; Gao, F; Armamento-Villareal, R; Jamalabadi-Majidi, S; Napoli, N; Ellis, MJ |Year=2011 |Journal=Breast Cancer Research and Treatment. |DOI=10.1007/s10549-011-1644-6 |Authors Abstract=Abstract A double-blind placebo-controlled randomized phase II trial was performed...")
- 07:33, 4 July 2024 CHoppe talk contribs created page Nasser et al. (2017): Vitamin D ointment for prevention of radiation dermatitis in breast cancer patients (Created page with "{{Reference |Reference=Publication: Vitamin D ointment for prevention of radiation dermatitis in breast cancer patients }} {{Study Note}} =Brief summary= In this study, the effectiveness of a vitamin D ointment was investigated with regard to typical adverse skin reactions associated with radiotherapy treatment. Breast cancer patients were given a vitamin D ointment on one side of the treated breast and a normal control ointment on the other half. There were no significa...")
- 07:31, 4 July 2024 CHoppe talk contribs created page Publication: Vitamin D ointment for prevention of radiation dermatitis in breast cancer patients (Created page with "{{Publication |Title=Vitamin D ointment for prevention of radiation dermatitis in breast cancer patients |Topic=Vitamin D |Author=Nasser, NJ; Fenig, S; Ravid, A; Nouriel, A; Ozery, N; Gardyn, S; Koren, R; Fenig, E |Year=2017 |Journal=NPJ Breast Cancer |DOI=10.1038/s41523-017-0006-x |Authors Abstract=Radiation dermatitis occurs frequently during adjuvant radiation therapy for breast cancer. Prevention of radiation dermatitis by applying various creams and ointments has a...")
- 11:45, 2 July 2024 CHoppe talk contribs created page Khan et al. (2017): Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial (Created page with "{{Reference |Reference=Publication: Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis...")
- 11:44, 2 July 2024 CHoppe talk contribs created page Publication: Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial (Created page with "{{Publication |Title=Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial |Topic=Vitamin D |Author=Khan, Q; Kimler, BF; Reddy, PS; Sharma, P; Klemp, JR; Nydegger, JL; Yeh, H-W; Fabian, CJ |Year=2017 |Journal=Breast Cancer Research and treatment |DOI=10.1007/s10549-017-4429-8 |Authors Abstract=Purpose: Aromatase inhibitor-associated musculoskeletal symptoms (AIMSS) frequen...")
- 10:33, 2 July 2024 CHoppe talk contribs created page Jacot et al. (2016): Impact of a tailored oral vitamin D supplementation regimen on serum 25-hydroxyvitamin D levels in early breast cancer patients: a randomized phase III study (Created page with "{{Reference |Reference=Publication: Impact of a tailored oral vitamin D supplementation regimen on serum 25-hydroxyvitamin D levels in early breast cancer patients: a randomized phase III study }} =Brief summary= In this study, two groups of breast cancer patients with vitamin D deficiency were examined who either received high doses of vitamin D (arm A) or standard vitamin D therapy (arm B) 7 to 12 months after the start of their chemotherapy. After 6 months, a higher r...")
- 10:32, 2 July 2024 CHoppe talk contribs created page Publication: Impact of a tailored oral vitamin D supplementation regimen on serum 25-hydroxyvitamin D levels in early breast cancer patients: a randomized phase III study (Created page with "{{Publication |Title=Impact of a tailored oral vitamin D supplementation regimen on serum 25-hydroxyvitamin D levels in early breast cancer patients: a randomized phase III study |Topic=Vitamin D |Author=Jacot, W; Firmin, N; Roca, L; Topart, D; Gallet, S; Durigova, A; Mirr, S; Abach, L; Pouderoux, S; D'Hondt, V; Bleuse, J; Lamy, P; Romieu, G |Year=2016 |Journal=Annals of Oncology |DOI=https://doi.org/10.1093/annonc/mdw145 |Authors Abstract=Background: A minority of early...")
- 07:00, 2 July 2024 CHoppe talk contribs created page Beer et al. (2007): Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators (Created page with "{{Reference |Reference=Publication: Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators }} =Brief summary= Beer (2007). This study also investigated the effectiveness of vitamin D in combination with docetaxel (a chemotherapeutic agent) in prostate cancer patients. One group received docetaxel and vitamin D and the other group docetaxel...")
- 06:50, 2 July 2024 CHoppe talk contribs created page Publication: Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators (Created page with "{{Publication |Title=Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators |Topic=Vitamin D |Author=Beer, T; Ryan, CW; Venner, PM; Petrylak, DP; Chatta, GS; Ruether, JD; Redfern, CH; Fehrenbacher, L; Saleh, MN; Waterhouse, DM; Carducci, MA; Vicario, D; Dreicer, R; Higano, CS; Ahmann, FR; Chi, KN; Henner, WD; Arroyo, A; Clow, FW; ASCENT Inv...")
- 05:37, 28 June 2024 CHoppe talk contribs created page Attia et al. (2008): Randomized, Double-Blinded Phase II Evaluation of Docetaxel with or without Doxercalciferol in Patients with Metastatic, Androgen-Independent Prostate Cancer (Created page with "{{Reference |Reference=Publication: Randomized, Double-Blinded Phase II Evaluation of Docetaxel with or without Doxercalciferol in Patients with Metastatic, Androgen-Independent Prostate Cancer }} =Brief summary= This study investigated the efficacy of vitamin D in combination with docetaxel (a chemotherapeutic agent) in prostate cancer patients. One group received docetaxel and vitamin D and the other group docetaxel and placebo. There were no significant differences be...")
- 05:34, 28 June 2024 CHoppe talk contribs created page Publication: Randomized, Double-Blinded Phase II Evaluation of Docetaxel with or without Doxercalciferol in Patients with Metastatic, Androgen-Independent Prostate Cancer (Created page with "{{Publication |Title=Randomized, Double-Blinded Phase II Evaluation of Docetaxel with or without Doxercalciferol in Patients with Metastatic, Androgen-Independent Prostate Cancer |Topic=Vitamin D |Author=Attia, S; Eickhoff, J; Wilding, G; McNeel, D; Blank, J; Ahuja, H; Jumonville, A; Eastman, M; Shevrin, D; Glode, M; Alberti, D; Staab, M J; Horvath, D; Straus, J; Marnocha, R; Liu, G |Year=2008 |Journal=Clinical Cancer Research |DOI=10.1158/1078-0432.CCR-07-4274 |Authors...")
- 11:38, 27 June 2024 CHoppe talk contribs created page Watanabe et al. (2010): Polaprezinc prevents oral mucositis associated with radiochemotherapy in patients with head and neck cancer (Created page with "{{Reference |Reference=Publication: Polaprezinc prevents oral mucositis associated with radiochemotherapy in patients with head and neck cancer }} =Brief summary= The study examined 31 patients with head and neck carcinoma. In addition to radiotherapy, half of the test subjects rinsed their oral cavity with a zinc solution and the other half with an azulene solution. The occurrence of inflammation of the oral mucosa (oral mucositis), pain and dry mouth (xerostomia) as we...")
- 11:35, 27 June 2024 CHoppe talk contribs created page Publication: Polaprezinc prevents oral mucositis associated with radiochemotherapy in patients with head and neck cancer (Created page with "{{Publication |Title=Polaprezinc prevents oral mucositis associated with radiochemotherapy in patients with head and neck cancer |Topic=Zinc |Author=Watanabe, T; Ishihara, M; Matsuura, K; Mizuta, K; Itoh, Y |Year=2010 |Journal=International journal of cancer |DOI=https://dx.doi.org/10.1002/ijc.25200 |Authors Abstract=Oral mucositis is frequent but serious adverse event associated with radiotherapy or radiochemotherapy in head and neck cancer severely impairs health-relat...")
- 10:55, 27 June 2024 CHoppe talk contribs created page Sangthawan et al. (2015): Effects of zinc sulfate supplementation on cell-mediated immune response in head and neck cancer patients treated with radiation therapy (Created page with "{{Reference |Reference=Publication: Effects of zinc sulfate supplementation on cell-mediated immune response in head and neck cancer patients treated with radiation therapy }} =Brief summary= The present study dealt with the question of the extent to which zinc supplementation influences the survival of patients with head and neck cancer. Seventy patients undergoing radiotherapy at the same time were randomly divided into two groups, one of which received zinc and the ot...")
- 10:53, 27 June 2024 CHoppe talk contribs created page Publication: Effects of zinc sulfate supplementation on cell-mediated immune response in head and neck cancer patients treated with radiation therapy (Created page with "{{Publication |Title=Effects of zinc sulfate supplementation on cell-mediated immune response in head and neck cancer patients treated with radiation therapy |Topic=Zinc |Author=Sangthawan, D; Phungrassami, T; Sinkitjarurnchai, W |Year=2015 |Journal=Nutrition and cancer |DOI=https://dx.doi.org/10.1080/01635581.2015.1004735 |Authors Abstract=Zinc deficiency is an important factor that impairs cellular immunity and contributes to low T lymphocyte counts in head and neck ca...")